GHK-Cu Copper Peptide Spray and Alzheimer's Disease
GHK-Cu Copper Peptide Spray and Alzheimer's Disease Alzheimer's Disease (AD) is the most common form of dementia, characterized by progressive neurodegeneration, cognitive decline, and memory loss. While the exact mechanisms behind AD are complex and multifaceted, research into potential therapeutic agents has led to the investigation of various peptides, one of which is the copper-binding tripeptide GHK-Cu. What is GHK-Cu? GHK-Cu, or glycyl-L-histidyl-L-lysine-copper complex, is a naturally occurring peptide in human plasma that has a high affinity for copper. Its concentration in human serum decreases with age, from an average of 200 ng/ml at age 20 to 80 ng/ml by age 60. This peptide has been studied for its regenerative, anti-inflammatory, and antioxidant properties, which extend to potential neuroprotective effects. GHK-Cu in Alzheimer's Disease Research Several studies have explored the relationship between GHK-Cu and neurodegenerative conditions like Alzheimer's....